Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Nordic Nanovector's Betalutin® Receives Fast-track Designation from US FDA for Marginal Zone Lymphoma

Monday, June 29, 2020

Nordic Nanovector ASA announces that the US Food and Drug Administration FDA has granted Fast Track designation for investigating Betalutin Lu lilotomab satetraxetan for the treatment of adult patients with relapsed or refractory marginal zone lympho...

Axsome Therapeutics Receives FDA Breakthrough Therapy Designation for AXS-05 for the Treatment of Alzheimer’s Disease Agitation

Saturday, June 27, 2020

Axsome Therapeutics Inc a biopharmaceutical company developing novel therapies for the management of central nervous system CNS disorders announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation for AXS for...

Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate

Friday, June 26, 2020

Moderna Inc a clinical stage biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines to create a new generation of transformative medicines for patients and Catalent Inc NYSE CTLT the leading global provider of advanced delivery...

Aldevron Announces Agreement with Ziopharm Oncology for neoGMP® Production of Sleeping Beauty Plasmid DNA to Express TCRs for Treatment of Solid Tumors

Friday, June 26, 2020

Aldevron a leading provider of products and services for the biotechnology industry announced an agreement with Ziopharm Oncology to produce plasmid DNA for T cell therapy of solid tumors Aldevron has developed the neoGMP service level designed to ad...

CSL Behring Agrees to Acquire Novel Late-Stage Gene Therapy Candidate for Hemophilia B Patients from uniQure

Thursday, June 25, 2020

Global biotherapeutics leader CSL Behring announced that it has agreed to acquire exclusive global license rights to commercialize an adenoassociated virus AAV gene therapy program AMT etranacogene dezaparvovec for the treatment of hemophilia B from...

Replicate Bioscience and Immunomic Therapeutics Form Collaboration to Combat Infectious Diseases and Cancers

Thursday, June 25, 2020

Replicate Bioscience Inc a privatelyheld biopharmaceutical company creating novel treatments to prevent drug resistance in cancers and Immunomic Therapeutics Inc ITI a privatelyheld clinicalstage biotechnology company pioneering the study of nucleic...

Linnaeus Therapeutics Announces Clinical Trial Collaboration Agreement with Merck to Evaluate LNS8801

Wednesday, June 24, 2020

Linnaeus Therapeutics Inc Linnaeus a privately held clinicalstage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics today announced that it has entered into a clinical collaborati...

Century Therapeutics Announces Acquisition of Empirica Therapeutics

Wednesday, June 24, 2020

Century Therapeutics announced its acquisition of Empirica Therapeutics to leverage its iPSCderived allogeneic cell therapies against glioblastoma GBM

Agenus and Betta Pharmaceuticals Enter Into a License Agreement for Balstilimab and Zalifrelimab in Greater China

Tuesday, June 23, 2020

Agenus Inc an immunooncology IO company with an extensive pipeline of agents designed to activate immune response to cancers announced today that it has entered into an agreement with Betta Pharmaceuticals SZ a top Chinese pharmaceutical company focu...

Sarepta Therapeutics and Codiak BioSciences Collaborate to Research and Develop Exosome-Based Therapeutics for Rare Diseases

Tuesday, June 23, 2020

Sarepta Therapeutics Inc the leader in precision genetic medicine for rare diseases and Codiak BioSciences Inc a company at the forefront of advancing engineered exosomes as a new class of biologic medicines today announced a global research and opti...